SEIA
BSX icon

Signature Estate & Investment Advisors’s Boston Scientific BSX Stock Holding History

Signature Estate & Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,628
Closed -$416K – 674
2026
Q1 		$416K Sell
6,628
-73,361
-92% -$5.87M 0.01% 458
2025
Q4 		$7.63M Buy
79,989
+10,071
+14% +$987K 0.15% 73
2025
Q3 		$6.83M Buy
69,918
+4,164
+6% +$431K 0.15% 76
2025
Q2 		$7.06M Buy
+65,754
New +$6.65M 0.16% 69

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Signature Estate & Investment Advisors's BSX Position: Q2 2026 in Review

Signature Estate & Investment Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,628 shares — an estimated $416K sold.

Signature Estate & Investment Advisors first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $7.63M in Q4 2025. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Signature Estate & Investment Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Signature Estate & Investment Advisors sold 6,628 Boston Scientific shares in Q2 2026, an estimated $416K.
  • Signature Estate & Investment Advisors first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Signature Estate & Investment Advisors's Boston Scientific position peaked at $7.63M in Q4 2025.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Signature Estate & Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.